Resumen de acción ABBOTINDIA
Abbott India Limited, junto con sus filiales, opera como empresa farmacéutica en la India. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 0/6 |
| Crecimiento futuro | 3/6 |
| Rendimiento pasado | 5/6 |
| Salud financiera | 6/6 |
| Dividendos | 5/6 |
Competidores de Abbott India Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | ₹27,723.40 |
| Máximo en las últimas 52 semanas | ₹30,521.00 |
| Mínimo de 52 semanas | ₹22,000.00 |
| Beta | 0.013 |
| 1Cambio en 1 mes | -5.37% |
| Variación en 3 meses | -7.52% |
| Cambio de 1 año | 17.08% |
| 3Variación en 3 años | 45.93% |
| Variación en 5 años | 116.57% |
| Variación desde la OPV | 3,514.52% |
Noticias y actualizaciones recientes
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Recent updates
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price
Oct 17Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Aug 31Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00
Jul 13Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jun 27Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 13Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year
May 12Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Feb 23Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price
Jan 07Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's
Jul 15Abbott India (NSE:ABBOTINDIA) Will Pay A Larger Dividend Than Last Year At ₹325.00
Jul 01Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹325.00
May 22With EPS Growth And More, Abbott India (NSE:ABBOTINDIA) Makes An Interesting Case
Apr 14Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt?
Mar 06Is Now The Time To Put Abbott India (NSE:ABBOTINDIA) On Your Watchlist?
Dec 31We Think Abbott India (NSE:ABBOTINDIA) Can Manage Its Debt With Ease
Mar 16Here's Why We Think Abbott India (NSE:ABBOTINDIA) Is Well Worth Watching
Jan 28A Look At The Intrinsic Value Of Abbott India Limited (NSE:ABBOTINDIA)
Dec 05Do Abbott India's (NSE:ABBOTINDIA) Earnings Warrant Your Attention?
Oct 30Abbott India (NSE:ABBOTINDIA) Has A Rock Solid Balance Sheet
Sep 18Should You Be Adding Abbott India (NSE:ABBOTINDIA) To Your Watchlist Today?
Jul 16How Does Abbott India Limited (NSE:ABBOTINDIA) Stand Up To These Simple Dividend Safety Checks?
Mar 24The Abbott India (NSE:ABBOTINDIA) Share Price Is Up 197% And Shareholders Are Boasting About It
Mar 03Is Weakness In Abbott India Limited (NSE:ABBOTINDIA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 04How Much Of Abbott India Limited (NSE:ABBOTINDIA) Do Institutions Own?
Jan 14
Abbott India Limited (NSE:ABBOTINDIA) Is An Attractive Dividend Stock - Here's Why
Dec 24Announcing: Abbott India (NSE:ABBOTINDIA) Stock Increased An Energizing 185% In The Last Five Years
Dec 03Is There More To The Story Than Abbott India's (NSE:ABBOTINDIA) Earnings Growth?
Nov 12Rentabilidad de los accionistas
| ABBOTINDIA | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 0.02% | 1.9% | 2.9% |
| 1Y | 17.1% | 42.6% | 27.9% |
Rentabilidad vs. Industria: Los resultados de ABBOTINDIA fueron inferiores a los de la industria Indian Pharmaceuticals, que obtuvo un rendimiento del 42.6% el año pasado.
Rentabilidad vs. Mercado: ABBOTINDIA obtuvo unos resultados inferiores a los del mercado Indian, que fueron del 27.9% el año pasado.
Volatilidad de los precios
| ABBOTINDIA volatility | |
|---|---|
| ABBOTINDIA Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Precio estable de las acciones: ABBOTINDIA no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ABBOTINDIA (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1910 | 3,814 | Swati Dalal | www.abbott.co.in |
Abbott India Limited, junto con sus filiales, opera como empresa farmacéutica en la India. La empresa ofrece productos farmacéuticos para gastroenterología, salud de la mujer, metabolismo, sistema nervioso central, vacunas y multiespecialidad, incluyendo insomnio, deficiencia de vitamina D, parto prematuro y tratamiento del dolor. Ofrece productos antiinfecciosos, cardiodiabéticos, hepatológicos, hormonales, neuropsiquiátricos, hepáticos, gennext y para el cuidado del consumidor.
Resumen de fundamentos de Abbott India Limited
| Estadísticas fundamentales de ABBOTINDIA | |
|---|---|
| Capitalización bursátil | ₹589.54b |
| Beneficios(TTM) | ₹12.85b |
| Ingresos (TTM) | ₹60.66b |
45.9x
Ratio precio-beneficio (PE)9.7x
Ratio precio-ventas (PS)¿Está ABBOTINDIA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ABBOTINDIA | |
|---|---|
| Ingresos | ₹60.66b |
| Coste de los ingresos | ₹33.43b |
| Beneficio bruto | ₹27.23b |
| Otros gastos | ₹14.39b |
| Beneficios | ₹12.85b |
Últimos beneficios comunicados
Sep 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 604.57 |
| Margen bruto | 44.89% |
| Margen de beneficio neto | 21.18% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado ABBOTINDIA a largo plazo?
Ver rendimiento histórico y comparativa